SMARTEST INVESTMENT
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Send us your smartest or dumbest investment story. If we publish it, you'll get a free copy of the `Motley Fool UK Investment Guide'. E-mail to UKColumn @fool.com or snail mail to Motley Fool, The Independent on Sunday, 1 Canada Square, London E14 5DL.
In 1992, I inherited some British American Tobacco (BAT) shares from a relative who had died of cancer. I sold these and bought Wellcome shares. When the company was taken over by Glaxo in 1995, I received cash and Glaxo shares. I invested the cash in more Glaxo shares. At the time of the takeover, Glaxo shares stood at pounds 6.90. GlaxoWellcome shares are now over pounds 19.
RJ, Swansea
The Fool responds: What can be more Foolish than long-term investments in a quality company whose ethical profile fits neatly with yours? Give yourself the credit you deserve for this excellent investment, you Fool!
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments